From: Investigation of a real-time EPID-based patient dose monitoring safety system using site-specific control limits
Treatment type
Treatment site
Number of plans or patients
Number of fields
Average cumulative χ pass-rate (%) (μ)
Lower control limit (%) (μ-3σ)
IMRT
Prostate
82
1055
89.1
75.6
Head and Neck
37
486
84.0
71.3
Rectum
18
259
80.9
71.1